Infectious Diseases in Critical Care Medicine

(ff) #1

  1. Narita M, Muder RR, Cacciarelli TV, et al. Protothecosis after liver transplantation. Liver Transpl
    2008; 14(8):1211–1215.

  2. Cercenado E, Ena J, Rodrı ́guez-Cre ́ixems M, et al. A conservative procedure for the diagnosis of
    catheter-related infections. Arch Intern Med 1990; 150:1417–1420.

  3. Mun ̃oz P, de la Torre J, Bouza E, et al. Invasive aspergillosis in transplant recipients. A large
    multicentric study. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy.
    American Society for Microbiology, 1996.

  4. Segall L, Moal MC, Doucet L, et al. Toxoplasmosis-associated hemophagocytic syndrome in renal
    transplantation. Transpl Int 2006; 19(1):78–80.

  5. Roman CD, Habibian MR, Martin WH. Identification of an infected left ventricular assist device after
    cardiac transplant by indium-111 WBC scintigraphy. Clin Nucl Med 2005; 30(1):16–17.

  6. Chang FY, Singh N, Gayowski T, et al. Fever in liver transplant recipients: changing spectrum of
    etiologic agents. Clin Infect Dis 1998; 26(1):59–65.

  7. Toogood GJ, Roake JA, Morris PJ. The relationship between fever and acute rejection or infection
    following renal transplantation in the cyclosporin era. Clin Transplant 1994; 8(4):373–377.

  8. von Muller L, Schliep C, Storck M, et al. Severe graft rejection, increased immunosuppression, and
    active CMV infection in renal transplantation. J Med Virol 2006; 78(3):394–399.

  9. Toupance O, Bouedjoro-Camus MC, et al. Cytomegalovirus-related disease and risk of acute
    rejection in renal transplant recipients: a cohort study with case-control analyses. Transpl Int 2000;
    13(6):413–419.

  10. Crespo-Leiro MG, Alonso-Pulpon L, Vazquez de Prada JA, et al. Malignancy after heart
    transplantation: incidence, prognosis and risk factors. Am J Transplant 2008; 8(5):1031–1039.

  11. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States.
    Am J Transplant 2004; 4(6):905–913.

  12. Heo JS, Park JW, Lee KW, et al. Posttransplantation lymphoproliferative disorder in pediatric liver
    transplantation. Transplant Proc 2004; 36(8):2307–2308.

  13. Singh N, Gayowski T, Marino IR, et al. Acute adrenal insufficiency in critically ill liver transplant
    recipients. Implications for diagnosis. Transplantation 1995; 59(12):1744–1745.

  14. Hummel M, Warnecke H, Schu ̈ler S, et al. [Risk of adrenal cortex insufficiency following heart
    transplantation]. Klin Wochenschr 1991; 69(6):269–273.

  15. Bromberg JS, Alfrey EJ, Barker CF, et al. Adrenal suppression and steroid supplementation in renal
    transplant recipients. Transplantation 1991; 51(2):385–390.

  16. Bromberg JS, Baliga P, Cofer JB, et al. Stress steroids are not required for patients receiving a renal
    allograft and undergoing operation. J Am Coll Surg 1995; 180(5):532–536.

  17. Rodger RS, Watson MJ, Sellars L, et al. Hypothalamic-pituitary-adrenocortical suppression
    and recovery in renal transplant patients returning to maintenance dialysis. Q J Med 1986;
    61(235):1039–1046.

  18. Sever MS, Tu ̈rkmen A, Yildiz A, et al. Fever in dialysis patients with recently rejected renal
    allografts. Int J Artif Organs 1998; 21(7):403–407.

  19. Khan A, Ortiz J, Jacobson L, et al. Posttransplant lymphoproliferative disease presenting as adrenal
    insufficiency: case report. Exp Clin Transplant 2005; 3(1):341–344.

  20. Dorschner L, Speich R, Ruschitzka F, et al. Everolimus-induced drug fever after heart trans-
    plantation. Transplantation 2004; 78(2):303–304.

  21. Mourad G, Rostaing L, Legendre C, et al. Sequential protocols using basiliximab versus
    antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids.
    Transplantation 2004; 78(4):584–590.

  22. Khan SU, Salloum J, O’Donovan PB, et al. Acute pulmonary edema after lung transplantation: the
    pulmonary reimplantation response. Chest 1999; 116(1):187–194.

  23. Husain S, Kwak EJ, Obman A, et al. Prospective assessment of PlateliaAspergillusgalactomannan
    antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant
    2004; 4(5):796–802.

  24. Kwak EJ, Husain S, Obman A, et al. Efficacy of galactomannan antigen in the PlateliaAspergillus
    enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin
    Microbiol 2004; 42(1):435–438.

  25. Fortun J, Martin-Davila P, Alvarez ME, et al.Aspergillusantigenemia sandwich-enzyme immuno-
    assay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients.
    Transplantation 2001; 71(1):145–149.

  26. Bouza E, Sousa D, Mun ̃oz P, et al. Bloodstream infections: a trial of the impact of different methods
    of reporting positive blood culture results. Clin Infect Dis 2004; 39(8):1161–1169.

  27. Yao FY, Saab S, Bass NM, et al. Prediction of survival after liver retransplantation for late graft
    failure based on preoperative prognostic scores. Hepatology 2004; 39(1):230–238.


418 Mun ̃oz et al.

Free download pdf